Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous StroMed Cell Therapy + PRP
- Development stage
- Preclinical
- Lead developer
- VivaTech
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
Autologous StroMed Cell Therapy + PRP is a combination regenerative therapy developed by VivaTech. It utilizes a patient's own adipose-derived stromal/stem cells (ADSCs), which are extracted using a proprietary ultrasound cavitation method (StroMed), combined with autologous platelet-rich plasma (PRP). The therapy is administered via intra-articular injection to treat osteoarthritis of the knee, hip, and shoulder. The mechanism of action relies on the synergistic effect of the ADSCs' regenerative potential and the growth factors provided by the PRP to facilitate tissue repair, reduce joint inflammation, and improve functional outcomes in patients with degenerative joint disease.
- Brand names
- StroMed
- Other names
- Autologous adipose-derived stromal/stem cells + Platelet Rich PlasmaAutologous StroMed cells + PRPStroMed Cell Therapy
Beyond the preview
Go deeper on Autologous StroMed Cell Therapy + PRP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Autologous StroMed Cell Therapy + PRP.